Herpesvirus medications

Last updated: September 12, 2024

Herpesvirus medications

Emergency Medicine (Clinical Year)

Emergency Medicine (Clinical Year)

Advanced cardiac life support (ACLS): Clinical
Pneumothorax: Clinical
Traumatic brain injury: Clinical
Neck trauma: Clinical
Chest trauma: Clinical
Shock: Clinical
Abdominal trauma: Clinical
Burns: Clinical
Bites and stings: Clinical
Toxidromes: Clinical
Stroke: Clinical
Seizures: Clinical
Dizziness and vertigo: Clinical
Lower back pain: Clinical
Headaches: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Muscle weakness: Clinical
Advanced cardiac life support (ACLS): Clinical
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Pericardial disease: Clinical
Valvular heart disease: Clinical
Chest trauma: Clinical
Shock: Clinical
Peripheral vascular disease: Clinical
Leg ulcers: Clinical
Aortic aneurysms and dissections: Clinical
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Loop diuretics
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Positive inotropic medications
Antiplatelet medications
Blistering skin disorders: Clinical
Bites and stings: Clinical
Burns: Clinical
Diabetes mellitus: Clinical
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Adrenal insufficiency: Clinical
Neck trauma: Clinical
Insulins
Mineralocorticoids and mineralocorticoid antagonists
Glucocorticoids
Abdominal pain: Clinical
Appendicitis: Clinical
Gastrointestinal bleeding: Clinical
Peptic ulcers and stomach cancer: Clinical
Inflammatory bowel disease: Clinical
Diverticular disease: Clinical
Gallbladder disorders: Clinical
Pancreatitis: Clinical
Cirrhosis: Clinical
Hernias: Clinical
Bowel obstruction: Clinical
Abdominal trauma: Clinical
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Blood products and transfusion: Clinical
Venous thromboembolism: Clinical
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Thrombolytics
Fever of unknown origin: Clinical
Infective endocarditis: Clinical
Pneumonia: Clinical
Tuberculosis: Pathology review
Diarrhea: Clinical
Urinary tract infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory acidosis: Clinical
Metabolic and respiratory alkalosis: Clinical
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Acute kidney injury: Clinical
Kidney stones: Clinical
Stroke: Clinical
Seizures: Clinical
Headaches: Clinical
Traumatic brain injury: Clinical
Lower back pain: Clinical
Spinal cord disorders: Pathology review
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Migraine medications
Osmotic diuretics
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid antagonists
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Acute respiratory distress syndrome: Clinical
Pleural effusion: Clinical
Pneumothorax: Clinical
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Joint pain: Clinical
Hypertensive disorders of pregnancy: Clinical
Antepartum hemorrhage: Clinical
Premature rupture of membranes: Clinical
Postpartum hemorrhage: Clinical
Pediatric infectious rashes: Clinical
Pediatric bone and joint infections: Clinical
Skin and soft tissue infections: Clinical
Substance misuse and addiction: Clinical
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Psychiatric emergencies: Pathology review

Transcript

Watch video only

Anti-herpes medications are a group of antiviral agents that treat herpes infections including herpes simplex virus, or HSV, but they can also treat other viral infections like varicella zoster virus, or VZV, and cytomegalovirus, or CMV.

They act by inhibiting viral DNA synthesis and thus, inhibiting viral proliferation.

Alright, now let’s start with HSV, which infects skin and mucosal epithelial cells.

There are two types of HSV, HSV1 and HSV2.

Generally speaking, HSV1 tends to cause infections “above the waist” mostly involving the lips, or labia, which is referred to as herpes labialis, and the mouth and the gingiva, which is called gingivostomatitis.

In rare cases, HSV1 can spread to the esophagus, causing esophagitis, or to the central nervous system, causing meningitis or encephalitis, typically affecting the temporal lobe.

On the other hand, HSV2 tends to cause infections “below the waist” affecting the genital organs, which is referred to as herpes genitalis.

HSV can also pass from a mother to a baby usually when the baby passes through the infected maternal vaginal secretions and can cause severe neonatal infections.

The typical presentation of a herpes infection is clusters of small, painful, fluid-filled blisters, that ooze and ulcerate. They eventually heal after a few weeks.

However, HSV also infects the nearby sensory neurons, which aren’t destroyed, but instead, they become a permanent home for the herpes virus. This is referred to as the latent phase of the infection and is typically asymptomatic.

From time to time, the herpes virus from the sensory neurons make a few viral copies of itself which can get released and infect the epithelial cells.

Alright, now let’s move on to varicella zoster virus. VZV causes a primary infection called varicella or chickenpox, which is characterized by a rash on the scalp, face, and trunk that contains macules, papules, vesicles, and scabs at the same time.

Now, from the neurons in the skin, VZV travels retrogradely to the nerve ganglia, where it remains dormant.

Later on, if the immune system weakens, due to aging, stress, or immunosuppressive therapy, the virus can be reactivated.

It can then travel back up through the sensory nerves, anterogradely to the skin and cause an infection in the innervated dermatome - that’s called herpes zoster or shingles.

Now, let’s talk a bit about cytomegalovirus. CMV causes mononucleosis, commonly known as “mono,” which presents with sore throat, fever, lymphadenopathy, malaise, headache, and resolves over a few weeks.

Now, in immunocompromised individuals, CMV can cause more severe infections including pneumonia, esophagitis, and retinitis which can lead to vision loss.

CMV can also pass from a mother to a baby via the placenta causing a potentially life-threatening congenital infection.

Alright, now depending on their mechanism of action, anti-herpes medications can be divided into two categories: the guanosine analogs, and the viral DNA polymerase inhibitors.

Let’s start with the guanosine analogs which include acyclovir; medications that are similar to acyclovir such as valacyclovir, penciclovir, famciclovir, ganciclovir, and valganciclovir.

Once they’re inside an infected cell, they get phosphorylated to a monophosphate form by a viral enzyme, which is called viral kinase.

For example, acyclovir is converted to the acyclovir monophosphate by the viral thymidine kinase, while ganciclovir is initially phosphorylated by the enzyme UL-97 kinase, which is found in CMV infected cells.

Next, the monophosphate form is phosphorylated twice to the active triphosphate form by cellular enzymes.

This triphosphate form acts as a guanosine analog which means that it’s similar in structure with the normal guanosine nucleotide.

When this analog is inserted into the replicating viral DNA, it causes the growing DNA chain to terminate and DNA synthesis is halted.

Okay, now resistance to these medications can be developed if there is a mutated form of the viral kinase which won’t phosphorylate the medication.

Alright, now let’s move on to indications. Acyclovir is active against HSV and VZV.

When it’s used orally it’s only partially absorbed and so oral acyclovir is used for mild mucocutaneous lesions and genital lesions or for herpes prophylaxis in immunocompromised individuals such as individuals with AIDS.

Now, intravenous acyclovir is the treatment of more severe herpes infections, such as HSV encephalitis.

Acyclovir has no effect on latent forms of HSV and VZV.

Key Takeaways

Herpes medications are antiviral agents used to treat herpes infection. They mainly work by interfering with DNA replication of Herpes simplex viruses. Commonly prescribed herpes medications include acyclovir, cidofovir, foscarnet, and valacyclovir. Side effects include nephrotoxicity, electrolyte imbalances, headaches, hallucinations, and seizures.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir." Antimicrobial Agents and Chemotherapy (1986)
  5. "Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir" Drug Design, Development and Therapy (2016)
  6. "Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients" Transplant Infectious Disease (2018)
  7. "Antiviral Drug Resistance of Human Cytomegalovirus" Clinical Microbiology Reviews (2010)